Informações:
Falhas:
ID
42676
Descrição
A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.; ODM derived from: https://clinicaltrials.gov/show/NCT00380380
Link
https://clinicaltrials.gov/show/NCT00380380
Palavras-chave
Versões (3)
- 09/03/2017 09/03/2017 -
- 10/03/2017 10/03/2017 -
- 17/09/2021 17/09/2021 -
Transferido a
17 de setembro de 2021
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes Mellitus, Type 2 NCT00380380
Eligibility Diabetes Mellitus, Type 2 NCT00380380
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 2 NCT00380380
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Antidiabetics | Washout Period Completion Able
Item
must be able to complete a 1-week wash-out of current anti-diabetic medications
boolean
C0935929 (UMLS CUI [1])
C1710661 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0085732 (UMLS CUI [2,3])
C1710661 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0085732 (UMLS CUI [2,3])
Pharmaceutical Preparations Resulting in Altered gastric motility | Cardiac agent Dose Stable
Item
cannot take any medications which may alter gastric motility except for cardiac medication at a stable dose
boolean
C0013227 (UMLS CUI [1,1])
C0332294 (UMLS CUI [1,2])
C0548822 (UMLS CUI [1,3])
C0007220 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
C0332294 (UMLS CUI [1,2])
C0548822 (UMLS CUI [1,3])
C0007220 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Blood Glucose criteria Fulfill
Item
blood glucose criteria must be met
boolean
C0005802 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Body mass index
Item
bmi <40
boolean
C1305855 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus Due to Injury of pancreas | Secondary diabetes mellitus
Item
history of type 1 diabetes, diabetes resulting from pancreatic injury, or secondary forms of diabetes
boolean
C0011854 (UMLS CUI [1])
C0011849 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0273163 (UMLS CUI [2,3])
C0271640 (UMLS CUI [3])
C0011849 (UMLS CUI [2,1])
C0678226 (UMLS CUI [2,2])
C0273163 (UMLS CUI [2,3])
C0271640 (UMLS CUI [3])
Insulin Patient need for | Thiazolidinediones
Item
need for insulin within 3 months or patients on thiazolidinediones
boolean
C0021641 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C1257987 (UMLS CUI [2])
C0686904 (UMLS CUI [1,2])
C1257987 (UMLS CUI [2])
Comorbidity | Complications of Diabetes Mellitus
Item
significant concommitant disease or complications of diabetes
boolean
C0009488 (UMLS CUI [1])
C0342257 (UMLS CUI [2])
C0342257 (UMLS CUI [2])
Gastrointestinal Surgical Procedure | Gastrointestinal symptom Positive
Item
patients with any history of gastrointestinal surgery or positive gastrointestinal symptons
boolean
C0524722 (UMLS CUI [1])
C0426576 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0426576 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
Liver function tests abnormal
Item
abnormal liver function tests as defined by the protocol
boolean
C0151766 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])